McKesson showcases new central fill solution at ASHP Mid-Year Clinical Meeting

Press enter to search
Close search
Open Menu

McKesson showcases new central fill solution at ASHP Mid-Year Clinical Meeting

By Michael Johnsen - 12/02/2016

LAS VEGAS – McKesson's High Volume Solutions group on Friday announced the  launch of Central Fill as a Service (CFaaS), a McKesson-operated, centralized solution that allows pharmacies to use central fill without the investment in equipment, inventory or staffing (other than a pharmacist). Instead of the traditional central fill model that requires significant upfront investment, CFaaS is available to customers through a per-prescription fee that can dramatically reduce the pharmacy’s per-prescription cost to dispense.

“We are excited to offer this new service to our customers who traditionally have not been able to take advantage of our Central Fill solutions,” stated Joe Tammaro, VP Sales, McKesson High Volume Solutions. “Central Fill as a Service allows our customers to benefit from a combination of many assets and tools available from McKesson, including distribution, inventory optimization, industry-leading pharmacy management systems, 340B inventory management and extensive central fill operational expertise.”

CFaaS incorporates McKesson’s industry-leading Central Fill pharmacy automation technology and operational expertise, integrated pharmacy workflow, vast pharmaceutical distribution network and patent-pending streamlined 340B ordering and inventory capabilities to create new revenue and cost savings opportunities for pharmacies that may not have the resources to build their own central fill facility. A team of McKesson High Volume Solutions pharmacy automation experts will work with each CFaaS customer to tailor the service to meet their specific business objectives.

Small chain pharmacies can benefit from CFaaS through increased efficiencies, reduced costs and a greater focus on patient care. This differentiation for small chains can help show value in patient care through a focus on payer performance criteria, including medication adherence.

And pharmacies that already operate a central fill facility in need of an upgrade may benefit from CFaaS as an alternative to investing capital in new or additional equipment. In addition, pharmacies can use the service to increase revenue by pursuing business in new markets such as Employee Fills, Mail Order, Specialty, 340B or Long Term Care.

McKesson is showcasing this new service along with its comprehensive suite of technology solutions and clinical expertise designed to help pharmacy leaders improve financial outcomes, increase supply chain efficiency and leverage actionable insights at the American Society of Health-System Pharmacists Midyear Clinical Meeting 2016, which runs from Dec. 4–8, 2016.

“Pharmacists are increasingly expected to champion initiatives designed to increase revenue and reduce costs while improving efficiency and patient care,” commented Mark Eastham, SVP and general manager, McKessonPharmacy Optimization. “Our pharmacy team, a group of trusted advisors that work with health systems to help elevate the value that pharmacy brings to the health system, can help identify opportunities and work with hospital pharmacies to achieve success in critical areas such as patient safety and quality outcomes: rigorous financial performance, employee collaboration for operational efficiency and integration of critical technology systems.”

Visitors to McKesson's ASHP booth will learn how the power of “&” can work for them by taking advantage of the McKesson's one-on-one consulting. Attendees of ASHP will have the opportunity to engage in one-on-one conversations with McKesson Pharmacy Optimization consultants. During this time, attendees can learn about best practices and solutions to challenges ranging from supply chain efficiency, to specialty and ambulatory pharmacy, to 340B and drug spend analysis. Additionally, McKesson experts will offer 10-minute hands-on training sessions to help customers manage drug shortages, drug spend and drug ordering.